According to the results, with high expression in patients with NSCLC, FTO had a high specificity and sensitivity in diagnosing the disease; joint detection of it with CEA or CYFRA21-1 demonstrated a higher sensitivity in diagnosing NSCLC compared with detection of CEA or CYFRA21-1 alone. The gene discussed is FTO; the disease is non-small cell lung carcinoma.